Cargando…

Neurochemical, histological, and behavioral profiling of the acute, sub‐acute, and chronic MPTP mouse model of Parkinsonʼs disease

Parkinson's disease (PD) is a heterogeneous multi‐systemic disorder unique to humans characterized by motor and non‐motor symptoms. Preclinical experimental models of PD present limitations and inconsistent neurochemical, histological, and behavioral readouts. The 1‐methyl‐4‐phenyl‐1,2,3,6‐tetr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santoro, Matteo, Fadda, Paola, Klephan, Katie J., Hull, Claire, Teismann, Peter, Platt, Bettina, Riedel, Gernot
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098710/ https://www.ncbi.nlm.nih.gov/pubmed/36184945 http://dx.doi.org/10.1111/jnc.15699

Ejemplares similares

Evidence for a role of adaptive immune response in the disease pathogenesis of the MPTP mouse model of Parkinson's disease
por: Martin, Heather L., et al.
Publicado: (2015)

The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson’s disease
por: Mustafa, S., et al.
Publicado: (2016)

The antioxidant and neurochemical activity of Apium graveolens L. and its ameliorative effect on MPTP-induced Parkinson-like symptoms in mice
por: Chonpathompikunlert, Pennapa, et al.
Publicado: (2018)

Safety and neurochemical profiles of acute and sub-chronic oral treatment with agmatine sulfate
por: Bergin, David H., et al.
Publicado: (2019)

The effect of neuronal conditional knock-out of peroxisome proliferator-activated receptors in the MPTP mouse model of Parkinson’s disease
por: Mounsey, R.B., et al.
Publicado: (2015)

Early Paradoxical Increase of Dopamine: A Neurochemical Study of Olfactory Bulb in Asymptomatic and Symptomatic MPTP Treated Monkeys
por: Pifl, Christian, et al.
Publicado: (2017)

Neurochemical changes in animal models of Parkinson’s disease
por: Baranyi, Mária, et al.
Publicado: (2013)

Protective Role of rAAV-NDI1, Serotype 5, in an Acute MPTP Mouse Parkinson's Model
por: Barber-Singh, Jennifer, et al.
Publicado: (2010)

Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson’s disease
por: St-Amour, Isabelle, et al.
Publicado: (2012)

Partial depletion and repopulation of microglia have different effects in the acute MPTP mouse model of Parkinson’s disease
por: Li, Qing, et al.
Publicado: (2021)

Trimethylamine N-Oxide Exacerbates Neuroinflammation and Motor Dysfunction in an Acute MPTP Mice Model of Parkinson’s Disease
por: Quan, Wei, et al.
Publicado: (2023)

Characterization of retinal function and structure in the MPTP murine model of Parkinson’s disease
por: Tran, Katie K. N., et al.
Publicado: (2022)

Restoration of intestinal function in an MPTP model of Parkinson’s Disease
por: Ellett, L. J., et al.
Publicado: (2016)

S100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway
por: Sathe, Kinnari, et al.
Publicado: (2012)

Neurochemical Approaches in the Laboratory Diagnosis of Parkinson and Parkinson Dementia Syndromes: A Review
por: Jesse, Sarah, et al.
Publicado: (2009)

Autotransphntation of the Cervical Sympathetic Ganglion into Monkeys With MPTP-Induced Parkinsonism
por: Itakura, Toru, et al.
Publicado: (1992)

Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease
por: Klemann, Cornelius J. H. M., et al.
Publicado: (2015)

Parkinson’s disease model in zebrafish using intraperitoneal MPTP injection
por: Omar, Noor Azzizah, et al.
Publicado: (2023)

An Investigation on the Clinical Features and Neurochemical Changes in Parkinson's Disease With Depression
por: Lian, Teng-Hong, et al.
Publicado: (2019)

Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity
por: Teismann, Peter, et al.
Publicado: (2012)

Influences of Chronic Mild Stress Exposure on Motor, Non-Motor Impairments and Neurochemical Variables in Specific Brain Areas of MPTP/Probenecid Induced Neurotoxicity in Mice
por: Janakiraman, Udaiyappan, et al.
Publicado: (2016)

Acute MPTP Treatment Impairs Dendritic Spine Density in the Mouse Hippocampus
por: Weerasinghe-Mudiyanselage, Poornima D. E., et al.
Publicado: (2021)

In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin
por: Santoro, Matteo, et al.
Publicado: (2016)

Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
por: Mounsey, Ross B., et al.
Publicado: (2015)

Social behavioral changes in MPTP-treated monkey model of Parkinson's disease
por: Durand, Elodie, et al.
Publicado: (2015)

Pretreatment of caffeine leads to partial neuroprotection in MPTP model of Parkinson's disease
por: Bagga, Puneet, et al.
Publicado: (2016)

The Neuroprotective Effects of Cinnamic Aldehyde in an MPTP Mouse Model of Parkinson’s Disease
por: Bae, Woom-Yee, et al.
Publicado: (2018)

Dynamic Changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson's Disease
por: Huang, Dongping, et al.
Publicado: (2017)

The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson’s disease
por: Schwenkgrub, Joanna, et al.
Publicado: (2017)

Preparation and Neuroprotective Activity of Glucuronomannan Oligosaccharides in an MPTP-Induced Parkinson’s Model
por: Liu, Yingjuan, et al.
Publicado: (2020)

Transplantation in the nonhuman primate MPTP model of Parkinson's disease: update and perspectives
por: Wianny, Florence, et al.
Publicado: (2017)

Gastrointestinal and metabolic function in the MPTP-treated macaque model of Parkinson's disease
por: Delamarre, Anna, et al.
Publicado: (2020)

Effect of Different MPTP Administration Intervals on Mouse Models of Parkinson's Disease
por: Ma, Yuanyuan, et al.
Publicado: (2022)

GM1 Oligosaccharide Efficacy in Parkinson’s Disease: Protection against MPTP
por: Fazzari, Maria, et al.
Publicado: (2023)

Curcumin reverses neurochemical, histological and immuno-histochemical alterations in the model of global brain ischemia
por: de Alcântara, Glaura Fernandes Teixeira, et al.
Publicado: (2016)

Neurochemical and motor changes in mice with combined mutations linked to Parkinson’s disease
por: Bai, Xiang, et al.
Publicado: (2017)

Structural and neurophysiological alterations in Parkinson’s disease are aligned with cortical neurochemical systems
por: Wiesman, Alex I., et al.
Publicado: (2023)

Retraction: Influences of Chronic Mild Stress Exposure on Motor, Non-Motor Impairments and Neurochemical Variables in Specific Brain Areas of MPTP/Probenecid Induced Neurotoxicity in Mice
Publicado: (2020)

Neuroprotective Effects of Jitai Tablet, a Traditional Chinese Medicine, on the MPTP-Induced Acute Model of Parkinson's Disease: Involvement of the Dopamine System
por: Liu, Jia, et al.
Publicado: (2014)

The MPTP Story
por: Langston, J. William
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_378i2dcb9agnu0aav0leim03t9